Neumora Therapeutics, Inc.
Q3 2023 13F Holders
Symbol
NMRA
CUSIP
640979100
Type
Equity
Class
COM
Num filings
40
Total reported value, excl. options
$620 M
Compare 2023 Q3 to
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q4
Manager
Report Date
Value ($000)
Shares
Option Type